Which 5 Stocks Fueled Wall Street’s 2% Rally in Q2 2023—and How to Reposition Your Portfolio Posted by Daniel Silva on July 28, 2024 Amazon Apple Bristol Myers Squibb Dexcom Dow Federal Reserve Meta Microsoft Nasdaq S&P 500 +
Dow Soars 654 Points: Dexcom Plunges 41% on Mixed Guidance, Bristol-Myers Up 11% After FDA Approval Posted by Daniel Silva on July 27, 2024 Amazon Apple Bristol Myers Squibb Dexcom Dow Meta Microsoft Nasdaq S&P 500 +